Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CAMP - Camp4 Therapeutics Corp

Close
5.485
-0.475   -8.660%

Share volume: 2,057
Last Updated: Fri 27 Dec 2024 08:29:11 PM CET
Radio and Television Broadcasting and Wireless Communications Equipment Manufacturing: -2.60%

PREVIOUS CLOSE
CHG
CHG%
$5.96
-0.48
-7.97%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 0%
Dept financing 24%
Liquidity 67%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-14.38%
1 Month
38.38%
3 Months
-39.46%
6 Months
-39.46%
1 Year
16.60%
2 Year
-92.89%
Key data
Stock price
$5.48
P/E Ratio 
0.00
DAY RANGE
$5.50 - $6.60
EPS 
-$2.75
52 WEEK RANGE
$0.26 - $12.30
52 WEEK CHANGE
$12.42
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
1.652 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$246,365
AVERAGE 30 VOLUME 
$165,616
Company detail
CEO: Josh Mandel-Brehm
Region: US
Website: www.camp4tx.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Radio and Television Broadcasting and Wireless Communications Equipment Manufacturing
Sector: Manufacturing

We are a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Our principal executive offices are located in Cambridge, Massachusetts.

Recent news